These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27836179)

  • 1. Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis.
    Aharoni R; Rosen C; Shezen E; Bar-Lev DD; Golani O; Reisner Y; Sela M; Arnon R
    J Neuroimmunol; 2016 Dec; 301():7-11. PubMed ID: 27836179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
    Aharoni R; Herschkovitz A; Eilam R; Blumberg-Hazan M; Sela M; Bruck W; Arnon R
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11358-63. PubMed ID: 18678887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
    Zilkha-Falb R; Kaushansky N; Kawakami N; Ben-Nun A
    J Neuroinflammation; 2016 Jan; 13():7. PubMed ID: 26747276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.
    Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM
    J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
    Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
    J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
    Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L
    J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis.
    Mathisen PM; Kawczak JA; Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 2001 Jun; 64(5):542-51. PubMed ID: 11391709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis.
    Chevalier AC; Rosenberger TA
    J Neurochem; 2017 Jun; 141(5):721-737. PubMed ID: 28369944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate.
    D Alessandro J; Garofalo K; Zhao G; Honan C; Duffner J; Capila I; Fier I; Kaundinya G; Kantor D; Ganguly T
    CNS Neurol Disord Drug Targets; 2017; 16(6):714-723. PubMed ID: 28240190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
    Aharoni R; Eilam R; Stock A; Vainshtein A; Shezen E; Gal H; Friedman N; Arnon R
    J Neuroimmunol; 2010 Aug; 225(1-2):100-11. PubMed ID: 20554028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous remyelination following prolonged inhibition of alpha4 integrin in chronic EAE.
    Piraino PS; Yednock TA; Messersmith EK; Pleiss MA; Freedman SB; Hammond RR; Karlik SJ
    J Neuroimmunol; 2005 Oct; 167(1-2):53-63. PubMed ID: 16095724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.